Freedom of Information request on ingredients in the HPV vaccine (FOI 21/1040)
Published 25 February 2022
© Crown copyright 2022
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-27-september-2021/freedom-of-information-request-on-ingredients-in-the-hpv-vaccine-foi-211040
1st October 2021
FOI 21/1040
Dear
The following link by NHS will help to explain why boys have are also receiving the HPV vaccine: HPV vaccine overview - NHS (www.nhs.uk)
You can find a link to the European Public Assessment Reports at the following links:
https://www.ema.europa.eu/en/medicines/human/EPAR/gardasil
https://www.ema.europa.eu/en/medicines/human/EPAR/gardasil-9
A list of the known, possible side effects and their frequency are listed within the Patient Information Leaflet (PIL) or the Summary of medicinal Products Characteristics (SmPC) for healthcare professionals. These documents can be found online for the HPV vaccine at http://www.mhra.gov.uk/spc-pil/
Details on vaccine damage payments can be found at the following link:
Vaccine Damage Payment - GOV.UK (www.gov.uk)
Kind Regards,
MHRA Customer Service Centre
Medicines and Healthcare products Regulatory Agency